`
`
`
`
`
`Filed On Behalf Of:
`
`Novartis AG and LTS Lohmann Therapie-Systeme AG
`
`By:
`
`Raymond R. Mandra
`ExelonPatchIPR@fchs.com
`(212) 218-2100
`
`
`
`Paper No. ____
`Date Filed: February 18, 2015
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`MYLAN PHARMACEUTICALS INC.,
`Petitioner
`
`v.
`
`NOVARTIS AG AND LTS LOHMANN THERAPIE-SYSTEME AG,
`Patent Owners
`
`
`
`Inter Partes Review No. 2015-00265
`
`
`U.S. Patent 6,316,023
`
`
` WAIVER OF PATENT OWNERS’ PRELIMINARY RESPONSE
`
`
`
`
`
`
`
`
`
`
`
`
`Pursuant to 37 C.F.R. §42.107(b), Patent Owners Novartis AG and
`
`LTS Lohmann Therapie-Systeme AG hereby elect to waive their preliminary
`
`response in this Inter Partes Review No. 2015-00265. As indicated in the
`
`Trial Practice Guide, no adverse inference should be taken by this election.
`
`See Office Patent Trial Practice Guide, Fed. Reg. Vol. 77, No. 157 (2012) at
`
`Section II.C. This election shall not constitute a waiver or admission by
`
`Patent Owners with respect to any material set forth in the Petition.
`
`
`
`
`
`
`
`
`
`
`
`
`
`Dated: February 18, 2015
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`/Raymond R. Mandra/
`Raymond R. Mandra
`Registration No. 34,382
`Lead Counsel for Patent Owner
`FITZPATRICK, CELLA,
`HARPER & SCINTO
`1290 Avenue of the Americas
`New York, NY 10104-3800
`Tel. 212-218-2100
`
`1
`
`
`
`
`
`
`Dated: February 18, 2015
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`I certify that a copy of the foregoing Waiver Of Patent Owners’
`
`Preliminary Response was served on February 18, 2015 by causing it to be
`
`sent by email to counsel for Petitioner at the following email addresses:
`
`BoxMylan@knobbe.com
`
`
`
`
`
`
`
`/Raymond R. Mandra/
`Raymond R. Mandra
`Registration No. 34,382
`FITZPATRICK, CELLA,
`HARPER & SCINTO
`1290 Avenue of the Americas
`New York, NY 10104-3800
`Tel. 212-218-2100
`
`2
`
`